Benign breast diseases

被引：44

作者：

Courtillot, Carine

Plu-Bureau, Genevieve

Binart, Nadine

Balleyguier, Corinne

Sigal-Zafrani, Brigitte

Goffin, Vincent

Kuttenn, Frederique

Kelly, Paul A.

Touraine, Philippe

机构：

[1] Univ Paris 05, APHP, GH Pitie Salpetriere, Dept Endocrinol & Reprod Med, F-75651 Paris 13, France

[2] Univ Paris 05, Fac Med Rene Descartes, INSERM, U809 Targets Peptide Hormones Regulating Fertil, F-75651 Paris 13, France

[3] Univ Paris 05, Fac Med Rene Descartes, INSERM, U808 Prolactin Growth Hormone & Tumors, Paris, France

[4] Inst Gustave Roussy, Dept Radiol, Villejuif, France

[5] Inst Curie, Dept Pathol, Paris, France

[6] Univ Paris 05, Hotel Dieu Hosp, APHP, Dept Reprod Med & Gynecol, Paris, France

[7] Univ Paris 05, Fac Med Rene Descartes, INSERM, U808 Hormone Targets, Paris, France

[8] Univ Paris 05, Fac Med Rene Descartes, INSERM, U808 809, Paris, France

来源：

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA | 2005年 / 10卷 / 04期

关键词：

benign breast tumors; estradiol; prolactin; growth factors;

D O I：

10.1007/s10911-006-9006-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Benign breast diseases have always been neglected in comparison to cancer, despite the fact that there are many more patients with such diseases than patients presenting to a breast clinic for cancer. Like normal breast tissues, benign breast diseases are under a complex system of controls by both systemic hormonal and local factors. In this review, we attempt to present an overview of the latest knowledge concerning the epidemiology, classification, clinical presentation, management, and physiopathology of these disorders.

引用

页码：325 / 335

页数：11

共 66 条

[51]

NOGUCHI S, 1995, CANCER, V76, P1779, DOI 10.1002/1097-0142(19951115)76:10<1779::AID-CNCR2820761015>3.0.CO

[52]

2-0

[53]

PARKS AG, 1959, ANN R COLL SURG ENGL, V25, P295

[54]

Pasqualini JR, 1997, INT J CANCER, V70, P639, DOI 10.1002/(SICI)1097-0215(19970317)70:6<639::AID-IJC2>3.0.CO